|Bid||1.0000 x 29200|
|Ask||1.0200 x 40000|
|Day's range||0.9640 - 1.0400|
|52-week range||0.8210 - 4.9000|
|Beta (5Y monthly)||3.02|
|PE ratio (TTM)||N/A|
|Earnings date||09 Feb 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||3.09|
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its second quarter fiscal year 2023 on Thursday, February 9, 2023 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the second quarter fiscal year 2023 after the close of markets that same day.
With discretionary spending under pressure, investors are shying away from this Canadian cannabis stock today.
Over a two-year span, investors have watched marijuana stocks go from the buzz of Wall Street to nothing short of a buzzkill. When Democrats took control of both houses of Congress in 2021 and President Joe Biden ascended to the Oval Office, it was believed that cannabis reform was likely.